PathGEN Dx Pte. Ltd.

PathGEN Dx Pte. Ltd. is rated 3 out of 5 in the category biotechnology. Read and write reviews about PathGEN Dx Pte. Ltd.. PathGEN Dx is the first spin-off company founded by scientists from the Genome Institute of Singapore, under the Agency for Science, Technology and Research (A*STAR), and aims to be a global solutions provider in the research, biosurveillance, and diagnostic markets. We conduct research and develop products for infectious disease diagnostics, biosurveillance, and epidemiology. Our proprietary PathGEN® PathChip Kit can efficiently detect clinically significant pathogens and potentially novel infectious disease threats. It can be used in private laboratories, research institutions, contract research organizations, and pharmaceutical companies where test results can be used to rapidly drive laboratory research and findings into clinical applications and interventions. PathGEN Dx was recently awarded a TECS POV grant from SPRING Singapore for its research work, and is a Powered by Affymetrix (PbA) partner.